Advanced search
Publication Cover
Acta Oncologica Volume 55, 2016 - Issue 3
Journal homepage
1,152
Views
2
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Second primary malignancy in Burkitt's lymphoma

Binay Kumar ShahSt. Joseph Regional Cancer Center and Blood Institute, Lewiston, Idaho, USACorrespondence[email protected]
&
Nibash BudhathokiSt. Joseph Regional Cancer Center and Blood Institute, Lewiston, Idaho, USA
Pages 396-398 | Received 13 Apr 2015, Accepted 20 May 2015, Published online: 13 Jun 2015

References

  • Surveillance, Epidemiology, and End Results (SEER) Program (Internet). Bethesda (MD): National Cancer Institute (US), Surveillence Research Program. 2014 Apr. [cited 2015 Jan]. Available from: http://seer.cancer.gov/.
  • Wilson JF, Jenkin RD, Anderson JR, Chilcote RR, Coccia P, Exelby PR, et al. Studies on the pathology of non-Hodgkin's lymphoma of childhood. I. The role of routine histopathology as a prognostic factor. A report from the Children's Cancer Study Group. Cancer 1984;53:1695–704.
  • Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin's lymphomas of childhood: An analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989;7:186–93.
  • Yustein JT, Dang CV. Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol 2007;14:375–81.
  • Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J, et al. Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996;14:925–34.
  • Lacasce A, Howard O, Lib S, Fisher D, Weng A, Neuberg D, et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: Preserved efficacy with decreased toxicity. Leuk Lymphoma 2004;45:761–7.
  • Thomas DA, Faderl S, O’Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer 2006;106:1569–80.
  • Boué F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F, et al. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 2006;24:4123–8.
  • Surveillance, Epidemiology, and End Results (SEER) Program (Internet). Bethesda (MD): National Cancer Institute (US), Surveillence Research Program. 2014 Apr. [cited 2015 Jan]. Available from: http://seer.cancer.gov/data/metadata.html
  • Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and a statistical study. Am J Cancer 1932;16:1358–414.
  • Curtis RE, Ries LA. New malignancies among cancer survivors: SEER Cancer Registries, 1973–2000. In: Curtis RE, Freedman DM, Ron E, et al. Methods. Bethesda, MD: National Cancer Institute; 2006. p 9–14.
  • Schoenberg BS, Myers MH. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977;40(4 Suppl):1892–8.
  • Coleman MP, Forman D, Bryant H, Butler J, Coleman MP, Forman D, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 2011; 377:127–38.
  • Cancer Survivorship [Internet]. Atlanta (GA): Center for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion. [cited 2015 Jan 15]. Available from http://www.cdc.gov/cancer/survivorship/pdf/survivorship_fs.pdf.
  • Aisenberg AC. Problems in Hodgkin's disease management. Blood 1999;93:761–79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.